Hadassah

From Life-Threatening Brain Bleed to Birth of a Daughter

Thursday, Dec 11 2014

Yoni and Gila Sibony with their new baby.

When Gila Sibony was six months pregnant, she suffered a life-threatening bleed in her brain. The Hadassah Medical Organization’s specialists saved her life, but she lost the baby. 

Fast forward about five years and Gila is the mother of a new baby girl, born at Hadassah.

"We owe my wife's life and our baby's life to the amazing staff in Hadassah’s two hospitals and all the supporters around the world who have made such advanced medicine possible,” relates Gila’s husband, Yoni.

Gila recalls how everything was going along smoothly with her first pregnancy until, suddenly, she experienced a severe headache and collapsed on her bed. She managed to roll herself over to the phone to call for help.

Senior Hadassah Neurologist Dr. Guy Rosenthal remembers receiving a phone call at 2:00 am, alerting him to Gila’s arrival in the emergency room. "When I saw her,” he says, “she had already slipped into a coma. One pupil was dilated and that's usually a negative sign. It can mean there is pressure not only on the brain, but also on the brain stem, and often a patient is on the verge of death."

A Cat scan revealed a large hematoma, a bleed within the brain. “It was about the size of a small child's fist,” Dr. Rosenthal recalls. “We had to take it out."

During surgery, Dr. Rosenthal and his team removed the top of Gila's skull to relieve the swelling and remove the huge blood clot. It had been caused by a brain arteriovenous malformation (AVM), which is characterized by an abnormal connection between the arteries and veins. The problem is congenital, but before this, Gila had not experienced any symptoms. Her pregnancy, however, put pressure on her system and caused the rupture.

Slowly, the swelling went down. Several weeks later, Gila began to wake up. "Recovery is a very slow process, but we were hopeful," Dr. Rosenthal says.

Eventually, Gila was well enough to begin a comprehensive rehabilitation program at Hadassah Hospital Mount Scopus. "We gathered a multidisciplinary team of doctors, nurses, speech therapists, occupational therapists, physical therapists, psychologists, and dieticians to help her," reports Dr. Isabella Schwartz, head of Physical Medicine and Rehabilitation.

Like a dangerous roadway, the affected part of her brain needed to be closed off. Neurosurgeon Prof. Jose Cohen inserted soft platinum coils, shaped like springs the size of a human hair, and neutralized the problem.

"My first dream was to sit up and have coffee with my husband," relates Gila. "I got there, and then I dreamt of walking. We kept raising the ante on my dreams."

Gila’s biggest dream was to become a mother. As Dr. Rosenthal explains, this presented a new risk for her. But, he says, “we consulted with the obstetric gynecological team and decided she could do it, particularly if she avoided the strain of childbirth by having a Cesarean birth."

Every stage was monitored at Hadassah. About a month ago, Gila gave birth to her daughter and she and Yoni named the baby Oreen, signifying light and joy.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Monday, May 7 2018

Hadassah Cardiac Specialists Are Collaborating with Colleagues to Save Syrian Children

In an effort to save the lives of Syrian children suffering from life-threatening and complex heart abnormalities, the Hadassah Medical Organization and the Baruch Padeh Medical Center in Poriya-Tiberias have launched a unique collaboration as part of the Israel Defense Forces’ Good Neighbor program.

READ MORE ›
alt_text

Monday, May 7 2018

Pluristem Stem Cell Therapy, Based on Hadassah Preclinical Research, Has Been Cleared by FDA

Pluristem Therapeutics has announced that its new cell therapy to treat acute radiation syndrome (PLX-R18), based on the pioneering studies performed within the laboratory of Prof. Raphael Gorodetsky at the Hadassah Medical Organization, has received clearance from the United States Food and Drug Administration to treat individuals who may have been acutely exposed to high-dose radiation as the result of a nuclear attack or accident.

READ MORE ›
alt_text

Thursday, May 3 2018

HMO Exclusive Call with Nurse Rely Alon

Please join us for an exclusive conference call with Dr. Rely Alon, Director, Division of Nursing & Health Professions, Wednesday May 9, 2018 from 10:00 - 11:00 am EDT

READ MORE ›
alt_text

Tuesday, Apr 17 2018

Predicting Clinical Outcomes for Multiple Sclerosis Patients: Cutting-Edge Research at Hadassah

More than two million people--two to three times more women--have multiple sclerosis (MS)--the leading cause of neurological disability among young adults. What is their prognosis?

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More